Efficacy and Safety of Pembrolizumab in Combination With Chemoradiotherapy Versus CRT Alone in Muscle-invasive Bladder Cancer
This study is designed to assess the antitumor efficacy and safety of pembrolizumab in combination with chemoradiotherapy (CRT) versus CRT alone in participants with muscle-invasive bladder cancer (MIBC). The primary hypothesis